Literature DB >> 16563437

Subclinical psychopathology and socio-economic status in unaffected twins discordant for affective disorder.

Maj Vinberg Christensen1, Kirsten Ohm Kyvik, Lars Vedel Kessing.   

Abstract

BACKGROUND: The most potent risk factor for affective disorders is a family history of affective disorder but the specific factors that are transmitted in families are unknown. It is possible to investigate the relation between risk factors and affective disorder by using a high-risk design e.g.: a study of the healthy relatives of patients with affective disorders. AIM: To compare psychopathology and socio-economic status between twins with a co-twin history of affective disorder and twins without.
METHODS: In a cross-sectional high-risk case-control study, healthy monozygotic and dizygotic twins with (High-Risk twins) and without (Low-Risk twins) a co-twin history of affective disorder were identified through nation-wide registers. Participants were assessed using semi-structured psychiatric interviews and self-rating of psychopathology.
RESULTS: High-Risk twins had a lower education level, a lower work position and tendency towards being more often unemployed and early retired than the Low-Risk twins. Furthermore, they presented higher rates of subclinical affective symptoms and were more likely to experience a minor psychiatric diagnosis.
CONCLUSION: Healthy twins with a high genetic liability to affective disorder seem to present lower socio-economic status, higher rates of subclinical affective symptoms and more often experience a minor psychiatric diagnosis than twins with no familial history of affective disorder. It is not possible from the present cross-sectional data to determine the causality of these findings, thus genetic liability to affective disorder, socio-economic status and minor psychopathology seem to have a complex interrelation.

Entities:  

Mesh:

Year:  2006        PMID: 16563437     DOI: 10.1016/j.jpsychires.2006.02.004

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  5 in total

1.  Healthy co-twins of patients with affective disorders show reduced risk-related activation of the insula during a monetary gambling task.

Authors:  Julian Macoveanu; Kamilla Miskowiak; Lars V Kessing; Maj Vinberg; Hartwig R Siebner
Journal:  J Psychiatry Neurosci       Date:  2016-01       Impact factor: 6.186

2.  DNA modification study of major depressive disorder: beyond locus-by-locus comparisons.

Authors:  Gabriel Oh; Sun-Chong Wang; Mrinal Pal; Zheng Fei Chen; Tarang Khare; Mamoru Tochigi; Catherine Ng; Yeqing A Yang; Andrew Kwan; Zachary A Kaminsky; Jonathan Mill; Cerisse Gunasinghe; Jennifer L Tackett; Irving I Gottesman; Gonneke Willemsen; Eco J C de Geus; Jacqueline M Vink; P Eline Slagboom; Naomi R Wray; Andrew C Heath; Grant W Montgomery; Gustavo Turecki; Nicholas G Martin; Dorret I Boomsma; Peter McGuffin; Rafal Kustra; Art Petronis
Journal:  Biol Psychiatry       Date:  2014-07-01       Impact factor: 13.382

3.  Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding.

Authors:  Vibe G Frokjaer; Maj Vinberg; David Erritzoe; William Baaré; Klaus Kähler Holst; Erik Lykke Mortensen; Haroon Arfan; Jacob Madsen; Terry L Jernigan; Lars Vedel Kessing; Gitte Moos Knudsen
Journal:  Neuropsychopharmacology       Date:  2009-12-30       Impact factor: 7.853

4.  Risk for affective disorders is associated with greater prefrontal gray matter volumes: A prospective longitudinal study.

Authors:  Julian Macoveanu; William Baaré; Kristoffer H Madsen; Lars Vedel Kessing; Hartwig Roman Siebner; Maj Vinberg
Journal:  Neuroimage Clin       Date:  2017-12-07       Impact factor: 4.881

5.  Clinical Characteristics, Life Adversities and Personality Traits in Monozygotic Twins With, at Risk of and Without Affective Disorders.

Authors:  Ninja M Ottesen; Iselin Meluken; Thomas Scheike; Lars V Kessing; Kamilla W Miskowiak; Maj Vinberg
Journal:  Front Psychiatry       Date:  2018-08-31       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.